Previous close | 25.60 |
Open | 25.65 |
Bid | 0.00 x 900 |
Ask | 0.00 x 900 |
Day's range | 25.33 - 26.59 |
52-week range | 22.96 - 79.75 |
Volume | |
Avg. volume | 431,153 |
Market cap | 1.226B |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | 19.49 |
EPS (TTM) | 1.34 |
Earnings date | 05 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 69.67 |
Prothena beats on earnings and revenues in the first quarter of 2022. The company's progress with its AD pipeline is encouraging.
Prothena (PRTA) delivered earnings and revenue surprises of 8.24% and 401.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Prothena (PRTA) has had a phenomenal run in the past year, primarily due to its promising pipeline for AD.